255 related articles for article (PubMed ID: 11744020)
1. Reversible activation of nuclear factor-kappaB in human end-stage heart failure after left ventricular mechanical support.
Grabellus F; Levkau B; Sokoll A; Welp H; Schmid C; Deng MC; Takeda A; Breithardt G; Baba HA
Cardiovasc Res; 2002 Jan; 53(1):124-30. PubMed ID: 11744020
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.
Castillero E; Ali ZA; Akashi H; Giangreco N; Wang C; Stöhr EJ; Ji R; Zhang X; Kheysin N; Park JS; Hegde S; Patel S; Stein S; Cuenca C; Leung D; Homma S; Tatonetti NP; Topkara VK; Takeda K; Colombo PC; Naka Y; Sweeney HL; Schulze PC; George I
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1463-H1476. PubMed ID: 30141986
[TBL] [Abstract][Full Text] [Related]
3. Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism.
Baba HA; Stypmann J; Grabellus F; Kirchhof P; Sokoll A; Schäfers M; Takeda A; Wilhelm MJ; Scheld HH; Takeda N; Breithardt G; Levkau B
Cardiovasc Res; 2003 Aug; 59(2):390-9. PubMed ID: 12909322
[TBL] [Abstract][Full Text] [Related]
4. Mechanical unloading increases caveolin expression in the failing human heart.
Uray IP; Connelly JH; Frazier OH; Taegtmeyer H; Davies PJ
Cardiovasc Res; 2003 Jul; 59(1):57-66. PubMed ID: 12829176
[TBL] [Abstract][Full Text] [Related]
5. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy.
Altemose GT; Gritsus V; Jeevanandam V; Goldman B; Margulies KB
J Heart Lung Transplant; 1997 Jul; 16(7):765-73. PubMed ID: 9257259
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of the human failing heart after left ventricular assist device support.
de Weger RA; Schipper ME; Siera-de Koning E; van der Weide P; van Oosterhout MF; Quadir R; Steenbergen-Nakken H; Lahpor JR; de Jonge N; Bovenschen N
J Heart Lung Transplant; 2011 May; 30(5):497-506. PubMed ID: 21211997
[TBL] [Abstract][Full Text] [Related]
7. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support.
Baba HA; Grabellus F; August C; Plenz G; Takeda A; Tjan TD; Schmid C; Deng MC
J Heart Lung Transplant; 2000 Jul; 19(7):668-74. PubMed ID: 10930816
[TBL] [Abstract][Full Text] [Related]
8. Cardiac unloading by LVAD support differentially influences components of the cGMP-PKG signaling pathway in ischemic and dilated cardiomyopathy.
Persoon S; Paulus M; Hirt S; Jungbauer C; Dietl A; Luchner A; Schmid C; Maier LS; Birner C
Heart Vessels; 2018 Aug; 33(8):948-957. PubMed ID: 29546540
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis, Bcl-2, and proliferating cell nuclear antigen in the failing human heart: observations made after implantation of left ventricular assist device.
Francis GS; Anwar F; Bank AJ; Kubo SH; Jessurun J
J Card Fail; 1999 Dec; 5(4):308-15. PubMed ID: 10634672
[TBL] [Abstract][Full Text] [Related]
11. Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.
Miyagawa S; Toda K; Nakamura T; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Saito T; Sawa Y
Surg Today; 2016 Feb; 46(2):149-54. PubMed ID: 25840890
[TBL] [Abstract][Full Text] [Related]
12. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
Chaudhary KW; Rossman EI; Piacentino V; Kenessey A; Weber C; Gaughan JP; Ojamaa K; Klein I; Bers DM; Houser SR; Margulies KB
J Am Coll Cardiol; 2004 Aug; 44(4):837-45. PubMed ID: 15312868
[TBL] [Abstract][Full Text] [Related]
13. Reduction of hypoxia-inducible heme oxygenase-1 in the myocardium after left ventricular mechanical support.
Grabellus F; Schmid C; Levkau B; Breukelmann D; Halloran PF; August C; Takeda N; Takeda A; Wilhelm M; Deng MC; Baba HA
J Pathol; 2002 Jun; 197(2):230-7. PubMed ID: 12015748
[TBL] [Abstract][Full Text] [Related]
14. Reverse remodeling following insertion of left ventricular assist devices (LVAD): a review of the morphological and molecular changes.
Wohlschlaeger J; Schmitz KJ; Schmid C; Schmid KW; Keul P; Takeda A; Weis S; Levkau B; Baba HA
Cardiovasc Res; 2005 Dec; 68(3):376-86. PubMed ID: 16024006
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin: a potential biomarker for heart failure and reverse remodeling after left ventricular assist device support.
Schipper ME; Scheenstra MR; van Kuik J; van Wichen DF; van der Weide P; Dullens HF; Lahpor J; de Jonge N; De Weger RA
J Heart Lung Transplant; 2011 Jul; 30(7):805-10. PubMed ID: 21531579
[TBL] [Abstract][Full Text] [Related]
16. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure.
Wong SC; Fukuchi M; Melnyk P; Rodger I; Giaid A
Circulation; 1998 Jul; 98(2):100-3. PubMed ID: 9679714
[TBL] [Abstract][Full Text] [Related]
17. Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation.
Khan T; Delgado RM; Radovancevic B; Torre-Amione G; Abrams J; Miller K; Myers T; Okerberg K; Stetson SJ; Gregoric I; Hernandez A; Frazier OH
J Heart Lung Transplant; 2003 Feb; 22(2):137-46. PubMed ID: 12581761
[TBL] [Abstract][Full Text] [Related]
18. [Left ventricular assist devices (LVAD): optional treatment alternative to cardiac transplantation?].
Wohlschlaeger J; Kawaguchi N; Levkau B; Schmid C; Scheld HH; Baba HA
Verh Dtsch Ges Pathol; 2004; 88():113-21. PubMed ID: 16892541
[TBL] [Abstract][Full Text] [Related]
19. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
[TBL] [Abstract][Full Text] [Related]
20. Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.
Klotz S; Jan Danser AH; Burkhoff D
Prog Biophys Mol Biol; 2008; 97(2-3):479-96. PubMed ID: 18394685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
